Between 1954 and 1975, in the Children’s Department of our Institute, 137 patients under the age of 14 were treated for cerebellar astrocytoma. Histological re-examination – in accordance with Gjerris and Klìnken – showed that only 128 cases could be included into the group of benign cerebellar astrocytomas. The short follow-up period in one part of our material does not allow the establishment of significant differences between the so-called ‘juvenile’ and ‘diffuse’ type of astrocytomas. From our investigations, it seems that the only significant factor in the recurrences and in the survival time is the involvement of the brain stem. This involvement is more frequent in the diffuse type. However, we could find long-term survivors in both histological groups.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.